Clinical trials
Not yet recruiting Phase 1 Glioma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 15 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Alabama at Birmingham | 2 |
| Beijing Bio-Targeting Therapeutics Technology Co., Ltd | 1 |
| Beijing Tiantan Hospital | 1 |
| City of Hope Medical Center | 1 |
| Hua Pang | 1 |
| Lumina Pharmaceuticals Inc | 1 |
| Megan Mantica | 1 |
| Ming Yang | 1 |
| NYU Langone Health | 1 |
| Nader Sanai | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioma | 20 |
| Brain Neoplasms | 5 |
| Glioblastoma | 5 |
| Diffuse Intrinsic Pontine Glioma | 3 |
| Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Pancreatic Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Colorectal Neoplasms | 1 |
| Esophageal Neoplasms | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.